Parmar Sahil

The India-US pharma relationship isn't just about trade—it's about affordable healthcare for millions of Americans. While Trump's policies create immediate challenges, they may accelerate India's transformation to become a true pharmaceutical innovator with global reach beyond the US market. What do you think will happen to global pharma/healthcare in the next 5 years? Share your thoughts below! 🔗 Disclaimer: http://ow.ly/63nS50Lqple#IndianPharma #HealthCare #GlobalEconomy #MotilalOswal #IndianPharma #HealthCare #GlobalEconomy #MotilalOswal

🚀 India’s Pharma and Healthcare sectors are on the rise! 💊 Pharma Highlights: ✅ Projected growth: 9-11% by FY26 ✅ Domestic launches & export demand are soaring ✅ PLI Scheme = Reduced dependency on imports 🏥 Healthcare Boost: ✅ Hospitals are more profitable with new beds, better occupancy rates, and higher patient realisations. 📈 Ready to invest in this thriving sector? Check out our curated Pharma and Healthcare stock basket on the Rise app today! #IndianPharma #MakeInIndia #RISEApp #MotilalOswal #IndianPharma #MakeInIndia #RISEApp #MotilalOswal